Trials / Recruiting
RecruitingNCT06463886
Striving Towards EmPowerment and Medication Adherence R01
A Randomized Control Trial of Striving Towards EmPowerment and Medication Adherence (STEP-AD)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- University of Miami · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a study for Black women living with HIV to test a counseling program for Black women living with HIV. This participant may be a good fit if the participant is a Black woman, living with HIV, has a history of trauma, and is currently taking Antiretroviral Therapy (ART) medicines
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | STEP-AD | This in-person STEP-AD intervention will consist of 10 sessions. Session 1: Life Steps Adherence Session 2: Psychoeducation on the treatment model Session 3: Substance Use and Enhancing Resilience Session 4: Trauma Impact Session 5: Cognitive Restructuring Session 6: Racial Discrimination Impact and Coping Session 7: HIV Stigma Impact and Coping Session 8: Gender-related Stressors and Coping Session 9: Body Image and Healthy Relationships Session 10: Practice, Review, and Relapse Prevention. Each session lasts for about 40 to 60 minutes. |
| BEHAVIORAL | Enhanced treatment as usual (E-TAU) | Participants assigned to the E-TAU condition will receive 10 in person sessions to ensure comparable contact time with study staff and identical incentives. The first session will consist of a session on healthy living with HIV (CDC content on HIV 101 \[highlights importance of engaging in care, adhering to medication, finding support\], nutrition, and physical activity. The remaining 9 sessions will consist of neutral (daily events) writing. Women will be asked to write a description of their plans for the next 24 hours. |
Timeline
- Start date
- 2024-08-19
- Primary completion
- 2029-06-01
- Completion
- 2029-06-01
- First posted
- 2024-06-18
- Last updated
- 2025-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06463886. Inclusion in this directory is not an endorsement.